Compare Heron Therapeutics Inc (HRTX) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs PPG Industries, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while PPG Industries, Inc. trades at $116.2 (market cap $25.79B). The key difference: PPG Industries, Inc. is far larger — about 282× Heron Therapeutics Inc's market cap, and PPG Industries, Inc. pays a 2.56% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PPG | |
|---|---|---|
Market Cap | $91.46M | $25.79B |
Sector | Health | Basic Materials |
52-Week High | $1.96 | $131.56 |
52-Week Low | $0.39 | $94.34 |
Enterprise Value | $189.36M | $31.90B |
Dividend Yield | — | 2.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
PPG Industries trades at $115.67, down 1.44% on the day. The stock shows a bullish technical trend with strong moving averages, while fundamentals reflect solid profitability with a 9.83% net income margin and a P/E of 16.81. Recent news highlights a dividend increase to $0.74 per share and innovation in aerospace coatings, signaling management's confidence in cash flow growth.
The outlook is positive, supported by analyst consensus with a $132.20 price target and 55% buy ratings. Key opportunities include steady dividend growth and aerospace sector strength, while risks involve economic sensitivity and debt levels. Earnings on July 28 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
